Skip to content

A Computer-Based ED Intervention to Improve Pediatric Asthma Medicine Adherence

A Computer-Based ED Intervention to Improve Pediatric Asthma Medicine Adherence

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02787174
Acronym
ED-AMAP
Enrollment
109
Registered
2016-06-01
Start date
2016-02-29
Completion date
2018-07-31
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

Asthma, Medication adherence, Intervention study

Brief summary

Asthma is common in children and impacts their health. There are effective medications for improving asthma, but some families have difficulty using medicines on a regular basis. This study in the emergency department will improve medicine use for children 2-12 years-old with asthma by developing content for a customized, tablet-based electronic intervention. A clinical trial will then be used to compare asthma outcomes for this intervention with routine asthma care.

Detailed description

The investigators have used focus groups to get ideas from parents of children with asthma to best design the intervention. This has helped us create the questions that are being used in the intervention, and make the computer program appealing and acceptable to parents of children with asthma. The investigators will study the success of the intervention for children who receive it compared to children who obtain routine emergency department care. Participants who receive the intervention will complete a series of questions on a tablet computer. Questions will guide creation of individualized education and advice to improve medication use for each participant. The intervention will also allow for customized communication with each child's primary care provider. The investigators will include educational boosters at 2 and 4 weeks after the intervention delivered as chosen by the participant (email / text / RSS / mail). Children in the routine asthma care arm will not receive the intervention, and instead will receive routine discharge instructions by the emergency room doctors. The investigators will compare the success of the intervention group to routine emergency department care by using a device (DOSER CT) that measures daily administered doses of medicine. Data from the DOSER CT will be collected monthly at home visits for three months. The investigators will also measure health care use and quality-of-life for each child using a survey at these home visits. The investigators believe that the intervention will improve doses of medicine given, reduce unnecessary health care use, and improve children's quality of life.

Interventions

OTHERAsthma Medication Adherence Education

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Rhode Island Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Asthma diagnosis by physician or parent report * Ages 2-12 * Prescribed an inhaled corticosteroid asthma controller medicine

Exclusion criteria

* Parent does not speak English * Child is prescribed inhaled corticosteroid seasonally * Patient is on a combination inhaled corticosteroid controller asthma med

Design outcomes

Primary

MeasureTime frameDescription
Asthma controller medication adherence12 weeksPercentage adherent days defined as at least half of prescribed doses taken as measured by Doser CT

Secondary

MeasureTime frameDescription
Unscheduled healthcare use (self-report survey and chart review)6 monthsUnscheduled healthcare use (Emergency Department visits, doctor visits, hospitalizations)
Quality-of-Life (QOL)6 monthsQOL measurement using Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF)
Sustained Asthma controller medication adherence3 monthsPercentage adherent days defined as at least half of prescribed doses taken as measured by Doser CT

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026